Activity in this selectionBiotech
- Rounds participated in
- 1
- Confirmed lead rounds
- —
1 roles undisclosed- New companies
- 1
First participation on record · 0 follow-on- Funding in participating rounds
- $140M
1 disclosed · full round size, not this investor’s share
Rounds
1 in this selectionMEDIPOSTDevelops allogeneic, umbilical cord blood-derived stem cell therapies for inflammation-driven deg...
Role not disclosed